Abiopharma

🔍 Dickerman Jeffrey F (Executive)

Company: EXPEDITORS INTERNATIONAL OF WASHINGTON INC (EXPD)

Report Date: 2026-05-06

Detailed Transactions and Holdings:

• Acquired 976 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: M | equity_swap_involved: false | shares_owned_after: 10,276.67 | transaction_form_type: 4
• Acquired 11 shares of Common Stock (Direct)
  Date: 2026-05-06 | Code: M | equity_swap_involved: false | shares_owned_after: 10,287.67 | transaction_form_type: 4
• Sold 389 shares of Common Stock at $153.08 per share (Direct)
  Date: 2026-05-06 | Code: F | equity_swap_involved: false | shares_owned_after: 9,898.67 | transaction_form_type: 4
• Sold 976 shares of Restricted Stock Units - 2025 RSUs (Derivative)
  Date: 2026-05-06 | Code: M | equity_swap_involved: false | shares_owned_after: 1,952.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 11 shares of Dividend Equivalent Rights - 2025 RSUs (Derivative)
  Date: 2026-05-06 | Code: M | equity_swap_involved: false | shares_owned_after: 23.56 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Each RSU and DER represent a contingent right to receive the economic equivalent of one common shares of the issuer. The RSUs and DERs vested on May 6, 2026.